lily tirzepatide Lilly's weight-loss drug reduces sleep apnea severity in late-stage trials Lilly releases Zepbound® (tirzepatide) single-dose

However, there is no FDA-approved indication for this use

Certain supplements may support recovery: B-complex vitamins replenish depleted micronutrients from rapid weight loss, and magnesium glycinate can reduce orthostatic symptoms

Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection

Risk Manag Healthc Policy

Other obesity-related conditions improved by GLP therapies include heart failure with preserved ejection fraction, cardiovascular disease, nonalcoholic steatohepatitis, and obstructive sleep apnea

Always consult with a licensed physician before starting any new treatment regimen